Literature DB >> 26900605

Pre-exposure to fine particulate matters may induce endotoxin tolerance in a mouse model.

Yuntao Bai1, Bo Lu2, Qinghua Sun1.   

Abstract

Exposure to low or moderate doses of lipopolysaccharides (LPS) renders the host tolerance to a subsequent lethal dose of LPS, which is termed as endotoxin tolerance. It is characterized as the decrease in production of pro-inflammatory cytokines and the increase in production of anti-inflammatory mediators in response to a second LPS challenge. The alteration of cytokine profile protects LPS-primed hosts against a normally lethal dose of subsequent LPS challenge. Nevertheless, whether other environmental factors also trigger endotoxin tolerance remains unclear. Both epidemiologic and experimental studies have provided a link between particulate matter and human health. Here, we speculated on the effect of fine particles priming on endotoxin tolerance in a mouse model.

Entities:  

Year:  2015        PMID: 26900605      PMCID: PMC4757438     

Source DB:  PubMed          Journal:  Austin J Environ Toxicol


  24 in total

1.  Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways.

Authors:  Thomas Kampfrath; Andrei Maiseyeu; Zhekang Ying; Zubair Shah; Jeffrey A Deiuliis; Xiaohua Xu; Nisharahmed Kherada; Robert D Brook; Kongara M Reddy; Nitin P Padture; Sampath Parthasarathy; Lung Chi Chen; Susan Moffatt-Bruce; Qinghua Sun; Henning Morawietz; Sanjay Rajagopalan
Journal:  Circ Res       Date:  2011-01-27       Impact factor: 17.367

Review 2.  Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases.

Authors:  Daniel W Neef; Alex M Jaeger; Dennis J Thiele
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

3.  Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20.

Authors:  Yanbao Xiong; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

4.  Major stress protein Hsp70 interacts with NF-kB regulatory complex in human T-lymphoma cells.

Authors:  I V Guzhova; Z A Darieva; A R Melo; B A Margulis
Journal:  Cell Stress Chaperones       Date:  1997-06       Impact factor: 3.667

Review 5.  Effect of long-term exposure to air pollution on type 2 diabetes mellitus risk: a systemic review and meta-analysis of cohort studies.

Authors:  Bin Wang; Donghua Xu; Zhaohai Jing; Dawei Liu; Shengli Yan; Yangang Wang
Journal:  Eur J Endocrinol       Date:  2014-11       Impact factor: 6.664

6.  Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma.

Authors:  Bethany E Schaffer; Kwon-Sik Park; Gloria Yiu; Jamie F Conklin; Chenwei Lin; Deborah L Burkhart; Anthony N Karnezis; E Alejandro Sweet-Cordero; Julien Sage
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

Review 7.  Ambient air pollution and pregnancy-induced hypertensive disorders: a systematic review and meta-analysis.

Authors:  Marie Pedersen; Leslie Stayner; Rémy Slama; Mette Sørensen; Francesc Figueras; Mark J Nieuwenhuijsen; Ole Raaschou-Nielsen; Payam Dadvand
Journal:  Hypertension       Date:  2014-06-16       Impact factor: 10.190

8.  Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration.

Authors:  C A Salkowski; G Detore; A Franks; M C Falk; S N Vogel
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

Review 9.  Air pollution and type 2 diabetes: mechanistic insights.

Authors:  Sanjay Rajagopalan; Robert D Brook
Journal:  Diabetes       Date:  2012-12       Impact factor: 9.461

Review 10.  Epidemiological time series studies of PM2.5 and daily mortality and hospital admissions: a systematic review and meta-analysis.

Authors:  R W Atkinson; S Kang; H R Anderson; I C Mills; H A Walton
Journal:  Thorax       Date:  2014-04-04       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.